CD4 and neoplasm: While CD4 T cells have been typically relegated to the ‘supporting cast’ of anti-tumor immune cells, studies in the last decade or so have shown that CD4 T cells with cytolytic properties are capable of being the main tumor-killing cell type in effective anti-tumor immune responses.